LLLie-Gang Liu

Lie-Gang Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lie-Gang Liu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Heng Guo

    Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang 832000, China

    1 shared publication
  • Jia He

    Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang 832000, China

    1 shared publication
  • Jia-Ming Liu

    Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang 832000, China

    1 shared publication
  • Jing-Yu Zhang

    Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang 832000, China

    1 shared publication
  • Mei Zhang

    Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang 832000, China

    1 shared publication
  • Ru-Lin Ma

    Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang 832000, China

    1 shared publication

Latest Publications

  • Open Access

    Association of Metabolic Syndrome with the Adiponectin to Homeostasis Model Assessment of Insulin Resistance Ratio

    by Yu-Song Ding, Shu-Xia Guo, Ru-Lin Ma, Shu-Gang Li, Heng Guo, Jing-Yu Zhang, Mei Zhang, Jia-Ming Liu, Jia He, Yi-Zhong Yan, et al.

    This study aimed at determining whether the adiponectin to HOMA‐IR (A/H) ratio is associated with MetS and MetS components and comparing the diagnostic efficacy of adiponectin, HOMA‐IR, and the A/H ratio in healthy, middle‐aged participants. MetS was assessed in 1628 Kazakh participants (men, 768; women, 860). The associations between adiponectin, HOMA‐IR, and the A/H ratio with the components of MetS and MetS were examined using logistic regression analysis and receiver operating characteristic (ROC) curves. Our results show that A/H ratio may be a better diagnostic marker for MetS than either HOMA‐IR or adiponectin alone, and it may serve as an important biomarker to determine an increased risk for MetS in healthy middle‐aged population.